Wright Lassiter III - 01 Oct 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III
Issuer symbol
DGX
Transactions as of
01 Oct 2025
Transactions value $
$0
Form type
4
Filing time
03 Oct 2025, 16:32:18
Previous filing
25 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lassiter Wright III Director 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS, SECAUCUS Sean D. Mersten, Attorney in Fact for Wright L. Lassiter, III 03 Oct 2025 0001805909

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Phantom Stock Units Award $0 +157 +30.09% $0.00 679 01 Oct 2025 Common Stock 157 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
F2 Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.